Petropavlovsk (POG) has announced results of its adverse weather-induced (are you reading Al Gore?) impact assessment at Andreevskaya East  – with both negative and positive outcomes.

AIM listed fraud Cloudtag (CTAG) has unveiled the rebrand of its product which may or may not exist and which despite being first launched almost a year ago has generated sales of exactly 0. That this has excited the moronic shareholders of this company as the followed the countdown clock on the company's website says everything about the pea-brained fools,

Hello Share Tasters. I hold more Trinity Mirror (TNI) shares than I am happy with. It’s the usual story of having invested many, many years ago and then failing to wave bye bye when the story changes for the worst.

Some folks are winding down for Christmas already. Idle wotsits! Steve Moore and I are, however very much hard at work and we will have not one but TWO fantastic share tips coming out TODAY, Friday 16th December, at 2 PM. Christmas shopping can wait. These share tips are too hot. They can't!

I start with a few explanations of how businesses work and how markets work for shareholders in Cloudtag (CTAG) and Optibiotix (OPTI), Then I mention two risers, Falanx (FLX) and Andalas (ADL) before moving on to Marechale (MAC), MySquar (MYSQ) and finally, in great detail, the 17 years of jam tomorrow bollocks that is Torotrak (TRK). Remember, as per podcast, - five share tips for a fiver - starts Monday at 7 AM, don't miss out sign up HERE

Earlier this week, Xtract Resources (XTR) announced an upcoming EGM to authorise the issuance of a further 9 billion shares, a mere 50% of the current share capital! Sounds like a lot but one needs to have a look again at the last heavily dilutive funding round in November to ascertain whether this is actually going to help.

Yesterday’s staggering RNS from CloudTag (CTAG) has already been covered brilliantly in the CloudTag Bearcast special with Tom Winnifrith at his acerbic best – an absolute must-listen - but I have a couple of other observations and am unable to leave the L1 conversion notice date lie alone just yet!

As joint house broker to the exponent of Securities fraud that is Advanced Oncotherapy (AVO), Beaufort has to sound bullish and has thus reiterated its speculative buy stance today. But read the note carefully. Beaufort is frit. I have highlighted key phrases that have not appeared before for you. Key phrases which show goalposts being moved and a broker that is sick of being made to look foolish.

Nomad Cairn has not resigned as adviser to Cloudtag (CTAG) even though it has lied to investors on a serial basis and committed Securities fraud. Cairn's reputation is thus in tatters. It thus begs the question of how any of its other clients are frauds, how many are simply not investment grade material and how many of the few good clients will want to be associated with the disgraced Nomad for much longer as it will not help their share prices to be linked to this rotten, stinking adviser. The clients are listed below by AIM or ISDX category.

Well I guess it is not dead yet, but ShareProphets AIM-China Filthy Forty poster-boy MoneySwap (SWAP) sure is pushing the line. Having bundled through shareholder authorities to get enough headroom available for a rescue bail-out at its last AGM even without a firm proposal on the table last June, apparently due to the urgency of the situation, here we are six months on and still there is no deal – and the company is running on the fumes of a series of emergency loans. What’s the point?!

On 29 November Optibiotix (OPTI) stated: "OptiBiotix reports that it has reached late stage commercial discussions with six commercial partners across its technology and product platforms.". The knockers said "jam tomorrow won't happen". This week the first of the six deals was announced and it is massive. More will follow as Adam Reynolds made clear yesterday exclusively HERE. The news is:

Now for the drill down in detail on the horseshite served up by liars and fraudsters Cloudtag (CTAG) and morally bankrupt Nomad Cairn in yesterday's disgraceful RNS - the overall take is HERE. Let us now look at the new distributor in the UK and Europe Nemesis. It will work alongside Second Chance which used to have an exclusive deal and was guaranteeing 2016 sales of $5.2 million, It has delivered nil. So will Nemesis do any better?

An easy odd one out contest. Which of the four below is the odd one out and why? Answers in the comments section below - deadline midnight Saturday 17 December.

Wow! I’d love to have been a fly on the wall over at Cairn Financial as the wording of last night’s no-one-is-watching-o’clock RNS from AIM-listed CloudTag (CTAG) was being, ahem, “discussed.” I wonder how long that lot took to put together….since last Friday? It was a real shocker.

Cloudtag (CTAG) has released an after hours RNS. It beggars belief that Nomad Cairn has signed off on this shite, More lies to compound earlier lies but also an admission of more breaches of AIM Rules and that 2016 sales will be zero, contrary to earlier lies. It is all utter horseshite and in this special podcast I take apart this statement bit by bit. It is a bad day for AIM. Cairn you should be ashamed and is beneath contempt. Cloudtag has lied and committed fraud and its shares are a sell with a 0p target.

Hello Share Pickers. I'm in the middle of one of those interminable train journeys where you pass loads of familiar town names everybody knows, but where nobody ever stops. In this case Wilmslow, Hereford, Leominster, Ludlow, Crewe, Craven Arms etc. Well, have you ever been there?

Earlier Adam and I chatted about Concepta (CPT). In this podcast we cover Optibiotix (OPTI) and Premaitha (NIPT).

In this podcast I revisit the vexed subject of Xtract Resources (XTR) which begs the question of when exactly I should sack Gary Newman and Steve Moore. Having seen a Christmas Carol last night I am inspired by my hero Scrooge, that is to say before he got all soppy, Guardian reading and pathetic in his old age. I also comment on Management Consulting (MMC) before returning at length to Cloudtag (CTAG). This time I play the ghost of Christmases yet to come with a warning for hapless Nomad Cairn. I also comment on Sula (SULA) with whom I met up yesterday.

Yesterday I was explaining how silly it was to say I was bashing Cloudtag (CTAG) because its CEO is Jewish. I am an ardent zionist and very keen on the Jews. The Welsh however, that is another matter altogether. Where do I start when it comes to the race of short, untrustworthy, bone idle, sheep molesting, welfare addicted whingers who blame all their woes on the English? Oh yes, I met a nice Welshman yesterday. Don't get me wrong some of my best friends are Welsh. Well my daughter anyway.

We tipped Amryt Pharma (AMYT) pre-consolidation at an effective 18.4p earlier this year and until last week it all went quiet. Now it has roared into life and the shares are 18.5p-20.5p. So what happened? And what next?